nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—ABCB1—esophageal cancer	0.767	1	CbGaD
Fesoterodine—Dry cough—Methotrexate—esophageal cancer	0.00627	0.0783	CcSEcCtD
Fesoterodine—Obstructive airways disorder—Methotrexate—esophageal cancer	0.00427	0.0533	CcSEcCtD
Fesoterodine—Infection—Carboplatin—esophageal cancer	0.00213	0.0267	CcSEcCtD
Fesoterodine—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.00193	0.0241	CcSEcCtD
Fesoterodine—Laryngeal pain—Capecitabine—esophageal cancer	0.00191	0.0239	CcSEcCtD
Fesoterodine—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00144	0.018	CcSEcCtD
Fesoterodine—Face oedema—Cisplatin—esophageal cancer	0.00124	0.0155	CcSEcCtD
Fesoterodine—Dry eye—Capecitabine—esophageal cancer	0.0012	0.015	CcSEcCtD
Fesoterodine—Gastroenteritis—Capecitabine—esophageal cancer	0.00107	0.0133	CcSEcCtD
Fesoterodine—Abdominal discomfort—Cisplatin—esophageal cancer	0.00106	0.0133	CcSEcCtD
Fesoterodine—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.00102	0.0128	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000934	0.0117	CcSEcCtD
Fesoterodine—Face oedema—Capecitabine—esophageal cancer	0.000912	0.0114	CcSEcCtD
Fesoterodine—Urinary retention—Capecitabine—esophageal cancer	0.000899	0.0112	CcSEcCtD
Fesoterodine—Urinary tract disorder—Cisplatin—esophageal cancer	0.000876	0.0109	CcSEcCtD
Fesoterodine—Urethral disorder—Cisplatin—esophageal cancer	0.000869	0.0109	CcSEcCtD
Fesoterodine—Dry skin—Capecitabine—esophageal cancer	0.000866	0.0108	CcSEcCtD
Fesoterodine—Abdominal pain upper—Capecitabine—esophageal cancer	0.000863	0.0108	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000833	0.0104	CcSEcCtD
Fesoterodine—Eye disorder—Cisplatin—esophageal cancer	0.000829	0.0104	CcSEcCtD
Fesoterodine—Cardiac disorder—Cisplatin—esophageal cancer	0.000823	0.0103	CcSEcCtD
Fesoterodine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000799	0.00998	CcSEcCtD
Fesoterodine—Angina pectoris—Capecitabine—esophageal cancer	0.000796	0.00994	CcSEcCtD
Fesoterodine—Abdominal discomfort—Capecitabine—esophageal cancer	0.000783	0.00978	CcSEcCtD
Fesoterodine—Dysuria—Capecitabine—esophageal cancer	0.000764	0.00954	CcSEcCtD
Fesoterodine—Flatulence—Cisplatin—esophageal cancer	0.000761	0.0095	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000759	0.00948	CcSEcCtD
Fesoterodine—Infestation NOS—Capecitabine—esophageal cancer	0.000728	0.0091	CcSEcCtD
Fesoterodine—Infestation—Capecitabine—esophageal cancer	0.000728	0.0091	CcSEcCtD
Fesoterodine—Vision blurred—Cisplatin—esophageal cancer	0.000728	0.00909	CcSEcCtD
Fesoterodine—Urinary tract infection—Capecitabine—esophageal cancer	0.000708	0.00884	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000689	0.0086	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000653	0.00815	CcSEcCtD
Fesoterodine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000646	0.00806	CcSEcCtD
Fesoterodine—Oedema peripheral—Capecitabine—esophageal cancer	0.000644	0.00804	CcSEcCtD
Fesoterodine—Urethral disorder—Capecitabine—esophageal cancer	0.000641	0.008	CcSEcCtD
Fesoterodine—Infection—Cisplatin—esophageal cancer	0.000626	0.00782	CcSEcCtD
Fesoterodine—Nervous system disorder—Cisplatin—esophageal cancer	0.000618	0.00772	CcSEcCtD
Fesoterodine—Tachycardia—Cisplatin—esophageal cancer	0.000615	0.00768	CcSEcCtD
Fesoterodine—Skin disorder—Cisplatin—esophageal cancer	0.000612	0.00764	CcSEcCtD
Fesoterodine—Eye disorder—Capecitabine—esophageal cancer	0.000611	0.00763	CcSEcCtD
Fesoterodine—Cardiac disorder—Capecitabine—esophageal cancer	0.000607	0.00758	CcSEcCtD
Fesoterodine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000589	0.00736	CcSEcCtD
Fesoterodine—Abdominal discomfort—Methotrexate—esophageal cancer	0.000583	0.00728	CcSEcCtD
Fesoterodine—Mental disorder—Capecitabine—esophageal cancer	0.000573	0.00715	CcSEcCtD
Fesoterodine—Dysuria—Methotrexate—esophageal cancer	0.000569	0.0071	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000565	0.00706	CcSEcCtD
Fesoterodine—Flatulence—Capecitabine—esophageal cancer	0.000561	0.007	CcSEcCtD
Fesoterodine—Dysgeusia—Capecitabine—esophageal cancer	0.000557	0.00696	CcSEcCtD
Fesoterodine—Back pain—Capecitabine—esophageal cancer	0.000551	0.00688	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000544	0.00679	CcSEcCtD
Fesoterodine—Infestation NOS—Methotrexate—esophageal cancer	0.000542	0.00677	CcSEcCtD
Fesoterodine—Infestation—Methotrexate—esophageal cancer	0.000542	0.00677	CcSEcCtD
Fesoterodine—Vision blurred—Capecitabine—esophageal cancer	0.000536	0.0067	CcSEcCtD
Fesoterodine—Feeling abnormal—Cisplatin—esophageal cancer	0.000519	0.00649	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000513	0.0064	CcSEcCtD
Fesoterodine—Vertigo—Capecitabine—esophageal cancer	0.000511	0.00639	CcSEcCtD
Fesoterodine—Palpitations—Capecitabine—esophageal cancer	0.000503	0.00628	CcSEcCtD
Fesoterodine—Cough—Capecitabine—esophageal cancer	0.000497	0.0062	CcSEcCtD
Fesoterodine—Chest pain—Capecitabine—esophageal cancer	0.000485	0.00605	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000481	0.00601	CcSEcCtD
Fesoterodine—Urinary tract disorder—Methotrexate—esophageal cancer	0.000481	0.006	CcSEcCtD
Fesoterodine—Urethral disorder—Methotrexate—esophageal cancer	0.000477	0.00596	CcSEcCtD
Fesoterodine—Dry mouth—Capecitabine—esophageal cancer	0.000474	0.00592	CcSEcCtD
Fesoterodine—Confusional state—Capecitabine—esophageal cancer	0.000468	0.00585	CcSEcCtD
Fesoterodine—Hypersensitivity—Cisplatin—esophageal cancer	0.000464	0.0058	CcSEcCtD
Fesoterodine—Infection—Capecitabine—esophageal cancer	0.000461	0.00576	CcSEcCtD
Fesoterodine—Nervous system disorder—Capecitabine—esophageal cancer	0.000456	0.00569	CcSEcCtD
Fesoterodine—Eye disorder—Methotrexate—esophageal cancer	0.000455	0.00568	CcSEcCtD
Fesoterodine—Tachycardia—Capecitabine—esophageal cancer	0.000453	0.00566	CcSEcCtD
Fesoterodine—Asthenia—Cisplatin—esophageal cancer	0.000452	0.00565	CcSEcCtD
Fesoterodine—Cardiac disorder—Methotrexate—esophageal cancer	0.000452	0.00564	CcSEcCtD
Fesoterodine—Skin disorder—Capecitabine—esophageal cancer	0.000451	0.00563	CcSEcCtD
Fesoterodine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000439	0.00548	CcSEcCtD
Fesoterodine—Diarrhoea—Cisplatin—esophageal cancer	0.000431	0.00538	CcSEcCtD
Fesoterodine—Mental disorder—Methotrexate—esophageal cancer	0.000426	0.00533	CcSEcCtD
Fesoterodine—Insomnia—Capecitabine—esophageal cancer	0.00042	0.00525	CcSEcCtD
Fesoterodine—Dysgeusia—Methotrexate—esophageal cancer	0.000415	0.00518	CcSEcCtD
Fesoterodine—Back pain—Methotrexate—esophageal cancer	0.00041	0.00512	CcSEcCtD
Fesoterodine—Dyspepsia—Capecitabine—esophageal cancer	0.000409	0.00511	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000401	0.00501	CcSEcCtD
Fesoterodine—Fatigue—Capecitabine—esophageal cancer	0.0004	0.005	CcSEcCtD
Fesoterodine—Vision blurred—Methotrexate—esophageal cancer	0.000399	0.00499	CcSEcCtD
Fesoterodine—Rash—Cisplatin—esophageal cancer	0.000397	0.00496	CcSEcCtD
Fesoterodine—Constipation—Capecitabine—esophageal cancer	0.000397	0.00496	CcSEcCtD
Fesoterodine—Dermatitis—Cisplatin—esophageal cancer	0.000397	0.00496	CcSEcCtD
Fesoterodine—Feeling abnormal—Capecitabine—esophageal cancer	0.000383	0.00478	CcSEcCtD
Fesoterodine—Vertigo—Methotrexate—esophageal cancer	0.000381	0.00475	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00038	0.00474	CcSEcCtD
Fesoterodine—Nausea—Cisplatin—esophageal cancer	0.000374	0.00467	CcSEcCtD
Fesoterodine—Cough—Methotrexate—esophageal cancer	0.00037	0.00462	CcSEcCtD
Fesoterodine—Urticaria—Capecitabine—esophageal cancer	0.000369	0.00461	CcSEcCtD
Fesoterodine—Abdominal pain—Capecitabine—esophageal cancer	0.000367	0.00459	CcSEcCtD
Fesoterodine—Chest pain—Methotrexate—esophageal cancer	0.000361	0.0045	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000358	0.00447	CcSEcCtD
Fesoterodine—Confusional state—Methotrexate—esophageal cancer	0.000349	0.00435	CcSEcCtD
Fesoterodine—Infection—Methotrexate—esophageal cancer	0.000344	0.00429	CcSEcCtD
Fesoterodine—Hypersensitivity—Capecitabine—esophageal cancer	0.000342	0.00427	CcSEcCtD
Fesoterodine—Nervous system disorder—Methotrexate—esophageal cancer	0.000339	0.00424	CcSEcCtD
Fesoterodine—Skin disorder—Methotrexate—esophageal cancer	0.000336	0.00419	CcSEcCtD
Fesoterodine—Asthenia—Capecitabine—esophageal cancer	0.000333	0.00416	CcSEcCtD
Fesoterodine—Pruritus—Capecitabine—esophageal cancer	0.000329	0.0041	CcSEcCtD
Fesoterodine—Diarrhoea—Capecitabine—esophageal cancer	0.000318	0.00397	CcSEcCtD
Fesoterodine—Insomnia—Methotrexate—esophageal cancer	0.000313	0.00391	CcSEcCtD
Fesoterodine—Somnolence—Methotrexate—esophageal cancer	0.000307	0.00384	CcSEcCtD
Fesoterodine—Dizziness—Capecitabine—esophageal cancer	0.000307	0.00384	CcSEcCtD
Fesoterodine—Dyspepsia—Methotrexate—esophageal cancer	0.000304	0.0038	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000299	0.00373	CcSEcCtD
Fesoterodine—Fatigue—Methotrexate—esophageal cancer	0.000298	0.00372	CcSEcCtD
Fesoterodine—Rash—Capecitabine—esophageal cancer	0.000293	0.00366	CcSEcCtD
Fesoterodine—Dermatitis—Capecitabine—esophageal cancer	0.000293	0.00365	CcSEcCtD
Fesoterodine—Headache—Capecitabine—esophageal cancer	0.000291	0.00363	CcSEcCtD
Fesoterodine—Feeling abnormal—Methotrexate—esophageal cancer	0.000285	0.00356	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000283	0.00353	CcSEcCtD
Fesoterodine—Nausea—Capecitabine—esophageal cancer	0.000276	0.00345	CcSEcCtD
Fesoterodine—Urticaria—Methotrexate—esophageal cancer	0.000275	0.00343	CcSEcCtD
Fesoterodine—Abdominal pain—Methotrexate—esophageal cancer	0.000273	0.00341	CcSEcCtD
Fesoterodine—Hypersensitivity—Methotrexate—esophageal cancer	0.000255	0.00318	CcSEcCtD
Fesoterodine—Asthenia—Methotrexate—esophageal cancer	0.000248	0.0031	CcSEcCtD
Fesoterodine—Pruritus—Methotrexate—esophageal cancer	0.000245	0.00306	CcSEcCtD
Fesoterodine—Diarrhoea—Methotrexate—esophageal cancer	0.000237	0.00295	CcSEcCtD
Fesoterodine—Dizziness—Methotrexate—esophageal cancer	0.000229	0.00286	CcSEcCtD
Fesoterodine—Rash—Methotrexate—esophageal cancer	0.000218	0.00272	CcSEcCtD
Fesoterodine—Dermatitis—Methotrexate—esophageal cancer	0.000218	0.00272	CcSEcCtD
Fesoterodine—Headache—Methotrexate—esophageal cancer	0.000217	0.00271	CcSEcCtD
Fesoterodine—Nausea—Methotrexate—esophageal cancer	0.000205	0.00257	CcSEcCtD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	5.95e-05	0.000388	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	5.93e-05	0.000387	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—FBXW7—esophageal cancer	5.92e-05	0.000387	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SST—esophageal cancer	5.91e-05	0.000386	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ALDH2—esophageal cancer	5.84e-05	0.000381	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—GHRL—esophageal cancer	5.76e-05	0.000376	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NOTCH3—esophageal cancer	5.76e-05	0.000376	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—FBXW7—esophageal cancer	5.67e-05	0.00037	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	5.66e-05	0.00037	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PLCE1—esophageal cancer	5.65e-05	0.000369	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ADH7—esophageal cancer	5.65e-05	0.000369	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—GSTT1—esophageal cancer	5.55e-05	0.000363	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	5.54e-05	0.000362	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HIST1H2BM—esophageal cancer	5.53e-05	0.000361	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PDE4D—esophageal cancer	5.49e-05	0.000359	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP2A6—esophageal cancer	5.49e-05	0.000358	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PDE4D—esophageal cancer	5.48e-05	0.000358	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	5.47e-05	0.000357	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	5.42e-05	0.000354	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NOTCH2—esophageal cancer	5.4e-05	0.000353	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ADH1B—esophageal cancer	5.26e-05	0.000343	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GNG7—esophageal cancer	5.23e-05	0.000341	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GNG7—esophageal cancer	5.21e-05	0.00034	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTGS1—esophageal cancer	5.2e-05	0.00034	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ENO1—esophageal cancer	5.2e-05	0.00034	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NOTCH2—esophageal cancer	5.17e-05	0.000338	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GNG7—esophageal cancer	5.16e-05	0.000337	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.14e-05	0.000336	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PSME1—esophageal cancer	5.13e-05	0.000335	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PSME2—esophageal cancer	5.13e-05	0.000335	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	5.11e-05	0.000334	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—BLVRB—esophageal cancer	5.11e-05	0.000334	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—TYMP—esophageal cancer	5.02e-05	0.000328	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ADH1B—esophageal cancer	4.95e-05	0.000324	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.93e-05	0.000322	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—XIAP—esophageal cancer	4.9e-05	0.00032	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP26A1—esophageal cancer	4.89e-05	0.000319	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—XIAP—esophageal cancer	4.88e-05	0.000319	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—XIAP—esophageal cancer	4.83e-05	0.000316	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.82e-05	0.000315	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TGFBR2—esophageal cancer	4.79e-05	0.000313	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ALOX15—esophageal cancer	4.76e-05	0.000311	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—TYMP—esophageal cancer	4.73e-05	0.000309	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CTNNA1—esophageal cancer	4.63e-05	0.000302	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CTNNA1—esophageal cancer	4.62e-05	0.000301	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	4.61e-05	0.000301	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CXCL2—esophageal cancer	4.6e-05	0.000301	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CXCL2—esophageal cancer	4.59e-05	0.0003	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TGFBR2—esophageal cancer	4.59e-05	0.000299	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	4.57e-05	0.000299	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	4.54e-05	0.000297	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTO1—esophageal cancer	4.54e-05	0.000297	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—TPI1—esophageal cancer	4.54e-05	0.000297	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SMAD4—esophageal cancer	4.53e-05	0.000296	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ALOX15—esophageal cancer	4.49e-05	0.000293	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP1B1—esophageal cancer	4.42e-05	0.000289	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ALDOB—esophageal cancer	4.36e-05	0.000285	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	4.34e-05	0.000284	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CA1—esophageal cancer	4.34e-05	0.000284	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SMAD4—esophageal cancer	4.34e-05	0.000283	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PSME1—esophageal cancer	4.3e-05	0.000281	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PSME2—esophageal cancer	4.3e-05	0.000281	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PSME1—esophageal cancer	4.29e-05	0.00028	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PSME2—esophageal cancer	4.29e-05	0.00028	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTO1—esophageal cancer	4.28e-05	0.00028	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—TPI1—esophageal cancer	4.28e-05	0.00028	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ANXA1—esophageal cancer	4.28e-05	0.00028	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ANXA1—esophageal cancer	4.27e-05	0.000279	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PSME2—esophageal cancer	4.25e-05	0.000277	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PSME1—esophageal cancer	4.25e-05	0.000277	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	4.23e-05	0.000276	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GAPDH—esophageal cancer	4.19e-05	0.000274	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	4.19e-05	0.000273	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SST—esophageal cancer	4.16e-05	0.000272	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP19A1—esophageal cancer	4.16e-05	0.000272	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CRABP1—esophageal cancer	4.16e-05	0.000271	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SST—esophageal cancer	4.15e-05	0.000271	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SST—esophageal cancer	4.11e-05	0.000268	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ALDOB—esophageal cancer	4.11e-05	0.000268	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NOTCH3—esophageal cancer	4.06e-05	0.000265	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GHRL—esophageal cancer	4.06e-05	0.000265	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	4.05e-05	0.000264	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GHRL—esophageal cancer	4.04e-05	0.000264	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NOTCH3—esophageal cancer	4.04e-05	0.000264	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	4.01e-05	0.000262	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GHRL—esophageal cancer	4.01e-05	0.000262	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—FBXW7—esophageal cancer	3.99e-05	0.000261	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—FBXW7—esophageal cancer	3.98e-05	0.00026	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CA2—esophageal cancer	3.97e-05	0.00026	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GNG7—esophageal cancer	3.95e-05	0.000258	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GAPDH—esophageal cancer	3.95e-05	0.000258	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	3.94e-05	0.000257	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CRABP1—esophageal cancer	3.92e-05	0.000256	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—HMOX1—esophageal cancer	3.8e-05	0.000248	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GNG7—esophageal cancer	3.72e-05	0.000243	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HIF1A—esophageal cancer	3.71e-05	0.000242	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ALDH2—esophageal cancer	3.7e-05	0.000242	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ADH7—esophageal cancer	3.69e-05	0.000241	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.69e-05	0.000241	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ABCB1—esophageal cancer	3.64e-05	0.000238	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	3.64e-05	0.000238	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NOTCH2—esophageal cancer	3.63e-05	0.000237	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	3.59e-05	0.000235	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HIF1A—esophageal cancer	3.55e-05	0.000232	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—KDR—esophageal cancer	3.55e-05	0.000232	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTT1—esophageal cancer	3.52e-05	0.00023	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ALDH2—esophageal cancer	3.49e-05	0.000228	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP2A6—esophageal cancer	3.48e-05	0.000227	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—KDR—esophageal cancer	3.4e-05	0.000222	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NOTCH1—esophageal cancer	3.34e-05	0.000218	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTT1—esophageal cancer	3.32e-05	0.000217	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS1—esophageal cancer	3.3e-05	0.000216	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ENO1—esophageal cancer	3.3e-05	0.000216	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.3e-05	0.000215	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	3.28e-05	0.000214	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PSME1—esophageal cancer	3.25e-05	0.000212	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PSME2—esophageal cancer	3.25e-05	0.000212	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ADH1B—esophageal cancer	3.24e-05	0.000212	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	3.23e-05	0.000211	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TGFBR2—esophageal cancer	3.22e-05	0.00021	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NOTCH1—esophageal cancer	3.2e-05	0.000209	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	3.19e-05	0.000208	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ENO1—esophageal cancer	3.11e-05	0.000203	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS1—esophageal cancer	3.11e-05	0.000203	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—TYMP—esophageal cancer	3.1e-05	0.000202	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PSME2—esophageal cancer	3.07e-05	0.0002	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PSME1—esophageal cancer	3.07e-05	0.0002	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	3.06e-05	0.0002	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SMAD4—esophageal cancer	3.05e-05	0.000199	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CREBBP—esophageal cancer	3.03e-05	0.000198	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	3.02e-05	0.000197	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	3.01e-05	0.000197	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—EGFR—esophageal cancer	2.98e-05	0.000194	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.93e-05	0.000192	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CREBBP—esophageal cancer	2.9e-05	0.000189	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—EGFR—esophageal cancer	2.85e-05	0.000186	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—PIK3CA—esophageal cancer	2.84e-05	0.000186	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.81e-05	0.000183	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.8e-05	0.000183	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—TPI1—esophageal cancer	2.8e-05	0.000183	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—PIK3CA—esophageal cancer	2.72e-05	0.000178	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NOS3—esophageal cancer	2.71e-05	0.000177	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.68e-05	0.000175	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2.65e-05	0.000173	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.64e-05	0.000172	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NOS3—esophageal cancer	2.6e-05	0.00017	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.58e-05	0.000169	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—PIK3CA—esophageal cancer	2.58e-05	0.000169	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.56e-05	0.000167	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ERBB2—esophageal cancer	2.54e-05	0.000166	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	2.5e-05	0.000163	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HIF1A—esophageal cancer	2.49e-05	0.000163	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	2.49e-05	0.000162	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—PIK3CA—esophageal cancer	2.47e-05	0.000162	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	2.47e-05	0.000161	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GNG7—esophageal cancer	2.44e-05	0.000159	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CREBBP—esophageal cancer	2.43e-05	0.000159	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ERBB2—esophageal cancer	2.43e-05	0.000159	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—HMOX1—esophageal cancer	2.41e-05	0.000157	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—KDR—esophageal cancer	2.39e-05	0.000156	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—KDR—esophageal cancer	2.38e-05	0.000156	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—KDR—esophageal cancer	2.36e-05	0.000154	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.28e-05	0.000149	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—HMOX1—esophageal cancer	2.27e-05	0.000148	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	2.25e-05	0.000147	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NOTCH1—esophageal cancer	2.25e-05	0.000147	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCND1—esophageal cancer	2.24e-05	0.000146	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	2.22e-05	0.000145	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—NOS3—esophageal cancer	2.18e-05	0.000142	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ABCB1—esophageal cancer	2.18e-05	0.000142	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.17e-05	0.000142	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CDKN1A—esophageal cancer	2.17e-05	0.000142	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCND1—esophageal cancer	2.15e-05	0.00014	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.15e-05	0.00014	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CDKN1A—esophageal cancer	2.08e-05	0.000136	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—EP300—esophageal cancer	2.06e-05	0.000135	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	2.04e-05	0.000133	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	2.04e-05	0.000133	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ENO1—esophageal cancer	2.03e-05	0.000133	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.03e-05	0.000133	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	2.02e-05	0.000132	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	2.01e-05	0.000131	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PSME2—esophageal cancer	2e-05	0.000131	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PSME1—esophageal cancer	2e-05	0.000131	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	2e-05	0.000131	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTGS2—esophageal cancer	1.99e-05	0.00013	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	1.98e-05	0.000129	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—EP300—esophageal cancer	1.98e-05	0.000129	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.92e-05	0.000125	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	1.91e-05	0.000125	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	1.89e-05	0.000124	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NOS3—esophageal cancer	1.83e-05	0.000119	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NOS3—esophageal cancer	1.82e-05	0.000119	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NOS3—esophageal cancer	1.81e-05	0.000118	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MYC—esophageal cancer	1.8e-05	0.000117	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—EGFR—esophageal cancer	1.76e-05	0.000115	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	1.74e-05	0.000114	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	1.74e-05	0.000113	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.73e-05	0.000113	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MYC—esophageal cancer	1.72e-05	0.000112	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	1.72e-05	0.000112	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	1.71e-05	0.000112	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	1.71e-05	0.000111	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	1.69e-05	0.00011	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—EGFR—esophageal cancer	1.68e-05	0.00011	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—EP300—esophageal cancer	1.66e-05	0.000108	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.63e-05	0.000106	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CREBBP—esophageal cancer	1.55e-05	0.000101	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PIK3CA—esophageal cancer	1.53e-05	9.97e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCND1—esophageal cancer	1.51e-05	9.87e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCND1—esophageal cancer	1.51e-05	9.84e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCND1—esophageal cancer	1.49e-05	9.74e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.48e-05	9.69e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TP53—esophageal cancer	1.48e-05	9.64e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	1.46e-05	9.55e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PIK3CA—esophageal cancer	1.46e-05	9.55e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	1.46e-05	9.52e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.46e-05	9.51e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	1.44e-05	9.43e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.42e-05	9.3e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TP53—esophageal cancer	1.41e-05	9.23e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—EP300—esophageal cancer	1.39e-05	9.09e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—EP300—esophageal cancer	1.39e-05	9.06e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—NOS3—esophageal cancer	1.38e-05	9.04e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—EP300—esophageal cancer	1.37e-05	8.97e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—NOS3—esophageal cancer	1.3e-05	8.51e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS2—esophageal cancer	1.27e-05	8.26e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PIK3CA—esophageal cancer	1.23e-05	8.01e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MYC—esophageal cancer	1.21e-05	7.92e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MYC—esophageal cancer	1.21e-05	7.89e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MYC—esophageal cancer	1.2e-05	7.82e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.19e-05	7.79e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—EGFR—esophageal cancer	1.19e-05	7.74e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—EGFR—esophageal cancer	1.18e-05	7.72e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—EGFR—esophageal cancer	1.17e-05	7.64e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—EP300—esophageal cancer	1.05e-05	6.87e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	1.03e-05	6.72e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	1.03e-05	6.7e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	1.02e-05	6.63e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TP53—esophageal cancer	9.96e-06	6.5e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TP53—esophageal cancer	9.92e-06	6.48e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—EP300—esophageal cancer	9.92e-06	6.48e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TP53—esophageal cancer	9.83e-06	6.42e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CREBBP—esophageal cancer	9.52e-06	6.22e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NOS3—esophageal cancer	8.52e-06	5.57e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS2—esophageal cancer	7.79e-06	5.09e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PIK3CA—esophageal cancer	7.78e-06	5.08e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	7.34e-06	4.79e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—EP300—esophageal cancer	6.48e-06	4.23e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.8e-06	3.13e-05	CbGpPWpGaD
